American journal of respiratory and critical care medicine 2023 Jan 01
Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias.
Related Questions
New answer by at University of Utah (April 12, 2024)
Yes, but not often. It always seems odd to me that patients and some providers want to wait until there's progression.I had a mentor who told me there were three certainties i...